Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Mercury Laboratories Limited is a pharmaceutical company engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2024 | Download
Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2024 | Download
Final • Div/Share: ₹ 3.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant